Subscribe
dna-istock-518143098-ralwel--2
ralwel / iStockphoto.com
30 November 2017Europe

CRISPR in Europe: the patent landscape for 2018

The Broad Institute of MIT and Harvard may lose a substantial number of European patent claims covering CRISPR/Cas9, but it has at least one trump card to play before we get to that stage, one European patent attorney has told LSIPR.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Africa
Clearing a way through the CRISPR patent jungle
8 May 2018   There may be a path through the CRISPR patent jungle, but there are many obstacles still in the way, say European academics Timo Minssen, Esther van Zimmeren and Jakob Wested.
Europe
CRISPR opposition hearing kicks off at EPO
16 January 2018   Today could play a pivotal role in the CRISPR patent landscape in Europe.
Europe
Broad Institute to appeal CRISPR patent revocation
17 January 2018   The Broad Institute of Harvard and MIT has said it will appeal against a decision by the European Patent Office to revoke one of its patents covering CRISPR/Cas9 technology.


Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

Editor's picks

Americas
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
24 October 2024

More on this story

Europe
Broad Institute to appeal CRISPR patent revocation
17 January 2018   The Broad Institute of Harvard and MIT has said it will appeal against a decision by the European Patent Office to revoke one of its patents covering CRISPR/Cas9 technology.
Europe
CRISPR opposition hearing kicks off at EPO
16 January 2018   Today could play a pivotal role in the CRISPR patent landscape in Europe.
Africa
Clearing a way through the CRISPR patent jungle
8 May 2018   There may be a path through the CRISPR patent jungle, but there are many obstacles still in the way, say European academics Timo Minssen, Esther van Zimmeren and Jakob Wested.

More on this story

Europe
Broad Institute to appeal CRISPR patent revocation
17 January 2018   The Broad Institute of Harvard and MIT has said it will appeal against a decision by the European Patent Office to revoke one of its patents covering CRISPR/Cas9 technology.
Europe
CRISPR opposition hearing kicks off at EPO
16 January 2018   Today could play a pivotal role in the CRISPR patent landscape in Europe.
Africa
Clearing a way through the CRISPR patent jungle
8 May 2018   There may be a path through the CRISPR patent jungle, but there are many obstacles still in the way, say European academics Timo Minssen, Esther van Zimmeren and Jakob Wested.

More features

Regulatory expert joins White & Case
Teva faces $500m fine for antitrust breaches over MS drug
UK Budget: A missed opportunity?
Pfizer infringed haemophilia therapy patent, says court
Cooley adds ex-Gowling partner
Apple wins just $250 in Masimo smartwatch clash
Amgen set for ‘at-risk’ launch of blockbuster eye drug biosimilar
Big Pharma counsel embrace AI but data and legal risks loom